These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25038821)

  • 1. Differentiation therapy: sesamin as an effective agent in targeting cancer stem-like side population cells of human gallbladder carcinoma.
    Kong X; Ma MZ; Zhang Y; Weng MZ; Gong W; Guo LQ; Zhang JX; Wang GD; Su Q; Quan ZW; Yang JR
    BMC Complement Altern Med; 2014 Jul; 14():254. PubMed ID: 25038821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emodin as an effective agent in targeting cancer stem-like side population cells of gallbladder carcinoma.
    Li XX; Dong Y; Wang W; Wang HL; Chen YY; Shi GY; Yi J; Wang J
    Stem Cells Dev; 2013 Feb; 22(4):554-66. PubMed ID: 22974371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sesamin exerts anti-tumor activity in esophageal squamous cell carcinoma via inhibition of TRIM44 and NF-κB signaling.
    Wen L; Mao W; Xu L; Cai B; Gu L
    Chem Biol Drug Des; 2022 Jan; 99(1):118-125. PubMed ID: 34411455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary screening and identification of stem cell-like sphere clones in a gallbladder cancer cell line GBC-SD.
    Yin BB; Wu SJ; Zong HJ; Ma BJ; Cai D
    J Zhejiang Univ Sci B; 2011 Apr; 12(4):256-63. PubMed ID: 21462380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maslinic acid potentiates the antitumor activities of gemcitabine in vitro and in vivo by inhibiting NF-κB-mediated survival signaling pathways in human gallbladder cancer cells.
    Yu Y; Wang J; Xia N; Li B; Jiang X
    Oncol Rep; 2015 Apr; 33(4):1683-90. PubMed ID: 25633045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of Pin1 as a Key Molecule for EMT Induction by Activation of STAT3 and NF-κB in Human Gallbladder Cancer.
    Nakada S; Kuboki S; Nojima H; Yoshitomi H; Furukawa K; Takayashiki T; Takano S; Miyazaki M; Ohtsuka M
    Ann Surg Oncol; 2019 Mar; 26(3):907-917. PubMed ID: 30610554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction.
    Huang JS; Yao CJ; Chuang SE; Yeh CT; Lee LM; Chen RM; Chao WJ; Whang-Peng J; Lai GM
    BMC Cancer; 2016 Mar; 16():245. PubMed ID: 27012679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway.
    Cao L; Fan X; Jing W; Liang Y; Chen R; Liu Y; Zhu M; Jia R; Wang H; Zhang X; Zhang Y; Zhou X; Zhao J; Guo Y
    Oncotarget; 2015 Mar; 6(9):6627-40. PubMed ID: 25749383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer stem-like side population cells in the human nasopharyngeal carcinoma cell line cne-2 possess epithelial mesenchymal transition properties in association with metastasis.
    Guo D; Xu BL; Zhang XH; Dong MM
    Oncol Rep; 2012 Jul; 28(1):241-7. PubMed ID: 22552840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sesamin manifests chemopreventive effects through the suppression of NF-kappa B-regulated cell survival, proliferation, invasion, and angiogenic gene products.
    Harikumar KB; Sung B; Tharakan ST; Pandey MK; Joy B; Guha S; Krishnan S; Aggarwal BB
    Mol Cancer Res; 2010 May; 8(5):751-61. PubMed ID: 20460401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nafamostat mesilate, a nuclear factor kappa B inhibitor, enhances the antitumor action of radiotherapy on gallbladder cancer cells.
    Takada N; Sugano H; Shirai Y; Saito N; Hamura R; Taniai T; Uwagawa T; Yanaga K; Ikegami T; Ohashi T; Eto K
    PLoS One; 2021; 16(9):e0257019. PubMed ID: 34473771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. URI regulates tumorigenicity and chemotherapeutic resistance of multiple myeloma by modulating IL-6 transcription.
    Fan JL; Zhang J; Dong LW; Fu WJ; Du J; Shi HG; Jiang H; Ye F; Xi H; Zhang CY; Hou J; Wang HY
    Cell Death Dis; 2014 Mar; 5(3):e1126. PubMed ID: 24625985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sesamin inhibits macrophage-induced vascular endothelial growth factor and matrix metalloproteinase-9 expression and proangiogenic activity in breast cancer cells.
    Lee CC; Liu KJ; Wu YC; Lin SJ; Chang CC; Huang TS
    Inflammation; 2011 Jun; 34(3):209-21. PubMed ID: 20617373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel inhibitor BRM270 downregulates tumorigenesis by suppression of NF-κB signaling cascade in MDR-induced stem like cancer-initiating cells.
    Mongre RK; Sodhi SS; Ghosh M; Kim JH; Kim N; Park YH; Kim SJ; Heo YJ; Sharma N; Jeong DK
    Int J Oncol; 2015; 46(6):2573-85. PubMed ID: 25872586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway.
    Pan MS; Wang H; Ansari KH; Li XP; Sun W; Fan YZ
    J Exp Clin Cancer Res; 2020 Nov; 39(1):234. PubMed ID: 33153467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Identification and characterization of stem cells in an ovarian cancer cell line and examination their drug resistance].
    Wei Z; Wang Y; Yu X; Zhang S
    Zhonghua Fu Chan Ke Za Zhi; 2015 Jun; 50(6):452-7. PubMed ID: 26311554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of the characteristics of side population cells in the human ovarian cancer cell line OVCAR-3].
    Luo LJ; Zhao Z; Zeng JF; Liang B; Yang JX; Cao DY; Shen K
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):281-5. PubMed ID: 22781115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of pancreatic cancer stem cells by flow cytometry and their biological characteristics.
    Li D; Su D; Xue L; Liu Y; Pang W
    Int J Clin Exp Pathol; 2015; 8(9):11218-23. PubMed ID: 26617845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sesamin inhibits lipopolysaccharide-induced proliferation and invasion through the p38-MAPK and NF-κB signaling pathways in prostate cancer cells.
    Xu P; Cai F; Liu X; Guo L
    Oncol Rep; 2015 Jun; 33(6):3117-23. PubMed ID: 25845399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sesamin suppresses STZ induced INS-1 cell apoptosis through inhibition of NF-κB activation and regulation of Bcl-2 family protein expression.
    Zheng S; Zhao M; Ren Y; Wu Y; Yang J
    Eur J Pharmacol; 2015 Mar; 750():52-8. PubMed ID: 25637086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.